Next big development will be the preliminary results of phase 2 for ARC-520, these results are due early Q3. Studies are fully enrolled and treatment is ongoing, study is scheduled to complete at end of q2. Not sure how they plan to handle responders, but it would be criminal to withdraw the drug from them if it has no sides and has a high knockdown.
ARC-520 works fast (in monkey ) so knockdown results should be available quick and some of the first patients may have a clue already as to how this is going.
Arrowhead has earnings results in early May and will hopefully provide a glimpse thru positive statements. I really think this is going I work and could be available in the next few years
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.